Non-Current Liabilities
Total Liabilities
Kailera Therapeutics Total Liabilities increased by 14.4% to $64.48M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
Detailed definition
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Peer comparison
Used across all industries to assess the overall debt burden relative to equity and assets.
Metric ID:
total_liabilitiesHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $56.39M | $64.48M |
| QoQ Change | — | +14.4% |
Range$56.39M – $64.48M
Total Liabilities at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's total liabilities?
- Kailera Therapeutics (KLRA) reported total liabilities of $64.48M in Q1 2026.
- What does total liabilities mean?
- The total amount of money the company owes to all creditors and stakeholders.